China Health Industries Holdings, Inc. (CHHE)

Market Cap	66.00
Revenue (ttm)	95.95K
Net Income (ttm)	-1.36M
Shares Out	65.54M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	503
Average Volume	2,367
Open	0.0000
Previous Close	0.2001
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 2.9600
Beta	-25.81
RSI	37.35
Earnings Date	Sep 15, 2025

About CHHE

China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brightening eye creams, hemp frozen age nourishing creams, hemp seed beers, and hemp seeds. It also provides health supplements, including Sailuozhi soft caps...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 34
• Stock Exchange: OTCMKTS
• Ticker Symbol: CHHE

Financial Performance

In 2023, CHHE's revenue was $111,579, an increase of 41689.89% compared to the previous year's $267. Losses were -$408,772, 15.5% more than in 2022.